MetaVia is trading 8.27% up at $1.67, apparently amid broader risk-on pre-market sentiment.
- It closed at $1.54 on September 16, 2026.
- No new company-specific announcement, earnings release, analyst action, or regulatory catalyst was identified for September 17; the latest notable company coverage concerns September 9 preclinical DA-1726 findings.
- Major U.S. indices are also higher; confidence is low because no direct catalyst was confirmed.